IDTA (IDenta) Moat Score: 2/10 (As of Jul. 01, 2026)


IDTA IDenta Corp IDTA
42 GF Score
Price $0.28
GF Value $0.32
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is IDenta Moat Score?

IDenta IDTA +7.84% 42 Moat Score is 2 as of Jul. 01, 2026. GuruFocus rates IDTA with a GF Score™ of 42/100 and a GF Value™ of $0.32 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 216 Medical Diagnostics & Research companies, IDenta ranks better than 69.44% on this metric.

IDenta has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

IDenta has No Moat: IDenta Corp has limited market presence and lacks significant intellectual property or brand strength. The company operates in a niche market with low barriers to entry, resulting in transient advantages.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes IDenta might have No Moat - Very weak/transient advantages.

IDenta  (OTCPK:IDTA) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

IDenta Moat Score Related Terms

IDTA vs NSTM, PRPH, NOTVQ: Moat Score Comparison

For the Diagnostics & Research subindustry, IDenta's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IDenta Moat Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDenta's Moat Score distribution charts can be found below:

* The bar in red indicates where IDenta's Moat Score falls into.


IDTA
42GF Score
IDenta Corp IDTA
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
IDenta (IDTA) has a Moat Score of 2 as of Jul. 01, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, IDenta ranks #66 out of 216 companies in the Medical Diagnostics & Research industry, placing it in the top 30.6%.
Is IDenta's Moat Score too high?
IDenta's current Moat Score is 2. Based on the distribution chart, IDenta ranks #66 out of 216 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, IDenta has a GF Score™ of 42/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IDenta's Moat Score compare to NSTM and PRPH?
According to the Medical Diagnostics & Research industry distribution chart, IDenta ranks #66 out of 216 companies for Moat Score. This puts IDenta in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Diagnostics & Research company?
A good Moat Score depends on the Medical Diagnostics & Research industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. IDenta's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDenta stock overvalued right now?
Based on GuruFocus' analysis, IDenta (IDTA) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.32, compared to a current price of $0.28 — trading 14.1% below its estimated fair value. The current Moat Score is 2. IDenta's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For IDenta (IDTA), the current Moat Score is 2 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IDenta (IDTA) Overvalued in 2026?

Based on GuruFocus' analysis, IDenta stock appears to be undervalued. The current stock price of $0.28 is trading 14.1% below its estimated GF Value™ of $0.32. GuruFocus considers IDenta to be Modestly Undervalued.

Key valuation signals for IDTA:

  • Moat Score: 2
  • GF Value™: $0.32 vs. price of $0.28 (14.1% below fair value)
  • GF Score™: 42/100 with 4 warning signs

No single metric tells the full story. See the IDTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IDenta Business Description

Address 3501 Keyser Avenue, Suite 22, Hollywood, FL, USA, 33021
IDenta Corp is a detection and forensic science company. The firm, through its subsidiary, is engaged in the business of developing products to test for the presence of illegal drugs and explosives for law enforcement agencies, ports and border crossings, shipping hubs, and other organizations. Its product portfolio includes Drug testing kits, Explosive testing kits, Forensic products, Urine drug testing and others. The company currently sells its products to law enforcement organizations in the following countries: Indonesia, Argentina, Poland, France, USA, Spain, India, the United Kingdom, Ghana, Nigeria, Australia, Russia, Israel, Canada, Germany, Italy, and Portugal. The company also sells to retail markets in the United States, Italy, and South Africa.
42GF Score

Get the complete analysis for IDTA

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.28
Price
$0.32
GF Value